HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-AUG-13 4M13 TITLE CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 8 [4- TITLE 2 (CARBAMOYLAMINO)-1-(7-PROPOXYNAPHTHALEN-1-YL)-1H-PYRAZOLE-3- TITLE 3 CARBOXAMIDE] COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ITK/TSK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 354-620; COMPND 5 SYNONYM: INTERLEUKIN-2-INDUCIBLE T-CELL KINASE, IL-2-INDUCIBLE T-CELL COMPND 6 KINASE, KINASE EMT, T-CELL-SPECIFIC KINASE, TYROSINE-PROTEIN KINASE COMPND 7 LYK; COMPND 8 EC: 2.7.10.2; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITK, EMT, LYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.HAN,N.L.CASPERS REVDAT 3 28-FEB-24 4M13 1 REMARK SEQADV REVDAT 2 04-JUN-14 4M13 1 JRNL REVDAT 1 02-APR-14 4M13 0 JRNL AUTH S.HAN,R.M.CZERWINSKI,N.L.CASPERS,D.C.LIMBURG,W.DING,H.WANG, JRNL AUTH 2 J.F.OHREN,F.RAJAMOHAN,T.J.MCLELLAN,R.UNWALLA,C.CHOI, JRNL AUTH 3 M.D.PARIKH,N.SETH,J.EDMONDS,C.PHILLIPS,S.SHAKYA,X.LI, JRNL AUTH 4 V.SPAULDING,S.HUGHES,A.COOK,C.ROBINSON,J.P.MATHIAS, JRNL AUTH 5 I.NAVRATILOVA,Q.G.MEDLEY,D.R.ANDERSON,R.G.KURUMBAIL, JRNL AUTH 6 A.AULABAUGH JRNL TITL SELECTIVELY TARGETING AN INACTIVE CONFORMATION OF JRNL TITL 2 INTERLEUKIN-2-INDUCIBLE T-CELL KINASE BY ALLOSTERIC JRNL TITL 3 INHIBITORS. JRNL REF BIOCHEM.J. V. 460 211 2014 JRNL REFN ISSN 0264-6021 JRNL PMID 24593284 JRNL DOI 10.1042/BJ20131139 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 21364 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.320 REMARK 3 FREE R VALUE TEST SET COUNT : 1136 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.94 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.90 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2948 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1988 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2759 REMARK 3 BIN R VALUE (WORKING SET) : 0.1958 REMARK 3 BIN FREE R VALUE : 0.2423 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.41 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 189 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2123 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 189 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.74000 REMARK 3 B22 (A**2) : 0.30050 REMARK 3 B33 (A**2) : 4.43950 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.89180 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.244 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.155 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2227 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3025 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 777 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 54 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 358 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2227 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 270 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2744 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.29 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.77 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|355 - A|618 } REMARK 3 ORIGIN FOR THE GROUP (A): 5.0989 2.7955 10.8929 REMARK 3 T TENSOR REMARK 3 T11: -0.0661 T22: -0.0577 REMARK 3 T33: -0.0651 T12: -0.0088 REMARK 3 T13: -0.0039 T23: -0.0015 REMARK 3 L TENSOR REMARK 3 L11: 0.2391 L22: 0.8179 REMARK 3 L33: 0.8124 L12: -0.2703 REMARK 3 L13: -0.1014 L23: 0.1128 REMARK 3 S TENSOR REMARK 3 S11: 0.0033 S12: 0.0041 S13: 0.0114 REMARK 3 S21: 0.0407 S22: 0.0070 S23: -0.0219 REMARK 3 S31: 0.0107 S32: 0.0265 S33: -0.0103 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4M13 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000081332. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-SEP-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21496 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER 2.11.2 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG3350, 0.1M MG ACETATE, 0.1 M REMARK 280 HEPES, PH 7.2, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.45000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AS PER THE AUTHORS THE BIOLOGICAL ASSEMBLY IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 352 REMARK 465 SER A 353 REMARK 465 GLY A 354 REMARK 465 GLY A 619 REMARK 465 LEU A 620 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 384 12.14 57.56 REMARK 500 LYS A 385 -83.23 -118.25 REMARK 500 ARG A 481 -24.24 90.49 REMARK 500 ASP A 482 47.66 -145.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1E0 A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4M0Y RELATED DB: PDB REMARK 900 RELATED ID: 4M0Z RELATED DB: PDB REMARK 900 RELATED ID: 4M12 RELATED DB: PDB REMARK 900 RELATED ID: 4M14 RELATED DB: PDB REMARK 900 RELATED ID: 4M15 RELATED DB: PDB DBREF 4M13 A 354 620 UNP Q08881 ITK_HUMAN 354 620 SEQADV 4M13 GLY A 352 UNP Q08881 EXPRESSION TAG SEQADV 4M13 SER A 353 UNP Q08881 EXPRESSION TAG SEQADV 4M13 ARG A 596 UNP Q08881 LYS 596 CONFLICT SEQRES 1 A 269 GLY SER GLY LYS TRP VAL ILE ASP PRO SER GLU LEU THR SEQRES 2 A 269 PHE VAL GLN GLU ILE GLY SER GLY GLN PHE GLY LEU VAL SEQRES 3 A 269 HIS LEU GLY TYR TRP LEU ASN LYS ASP LYS VAL ALA ILE SEQRES 4 A 269 LYS THR ILE ARG GLU GLY ALA MET SER GLU GLU ASP PHE SEQRES 5 A 269 ILE GLU GLU ALA GLU VAL MET MET LYS LEU SER HIS PRO SEQRES 6 A 269 LYS LEU VAL GLN LEU TYR GLY VAL CYS LEU GLU GLN ALA SEQRES 7 A 269 PRO ILE CYS LEU VAL PHE GLU PHE MET GLU HIS GLY CYS SEQRES 8 A 269 LEU SER ASP TYR LEU ARG THR GLN ARG GLY LEU PHE ALA SEQRES 9 A 269 ALA GLU THR LEU LEU GLY MET CYS LEU ASP VAL CYS GLU SEQRES 10 A 269 GLY MET ALA TYR LEU GLU GLU ALA CYS VAL ILE HIS ARG SEQRES 11 A 269 ASP LEU ALA ALA ARG ASN CYS LEU VAL GLY GLU ASN GLN SEQRES 12 A 269 VAL ILE LYS VAL SER ASP PHE GLY MET THR ARG PHE VAL SEQRES 13 A 269 LEU ASP ASP GLN TYR THR SER SER THR GLY THR LYS PHE SEQRES 14 A 269 PRO VAL LYS TRP ALA SER PRO GLU VAL PHE SER PHE SER SEQRES 15 A 269 ARG TYR SER SER LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 16 A 269 LEU MET TRP GLU VAL PHE SER GLU GLY LYS ILE PRO TYR SEQRES 17 A 269 GLU ASN ARG SER ASN SER GLU VAL VAL GLU ASP ILE SER SEQRES 18 A 269 THR GLY PHE ARG LEU TYR LYS PRO ARG LEU ALA SER THR SEQRES 19 A 269 HIS VAL TYR GLN ILE MET ASN HIS CYS TRP ARG GLU ARG SEQRES 20 A 269 PRO GLU ASP ARG PRO ALA PHE SER ARG LEU LEU ARG GLN SEQRES 21 A 269 LEU ALA GLU ILE ALA GLU SER GLY LEU HET 1E0 A 701 45 HETNAM 1E0 4-(CARBAMOYLAMINO)-1-(7-PROPOXYNAPHTHALEN-1-YL)-1H- HETNAM 2 1E0 PYRAZOLE-3-CARBOXAMIDE FORMUL 2 1E0 C18 H19 N5 O3 FORMUL 3 HOH *189(H2 O) HELIX 1 1 ASP A 359 SER A 361 5 3 HELIX 2 2 SER A 399 MET A 411 1 13 HELIX 3 3 CYS A 442 GLN A 450 1 9 HELIX 4 4 ALA A 455 ALA A 476 1 22 HELIX 5 5 ALA A 484 ARG A 486 5 3 HELIX 6 6 GLU A 492 GLN A 494 5 3 HELIX 7 7 GLY A 502 PHE A 506 5 5 HELIX 8 8 ASP A 509 SER A 514 1 6 HELIX 9 9 PRO A 521 ALA A 525 5 5 HELIX 10 10 SER A 526 SER A 533 1 8 HELIX 11 11 SER A 536 SER A 553 1 18 HELIX 12 12 SER A 563 THR A 573 1 11 HELIX 13 13 SER A 584 TRP A 595 1 12 HELIX 14 14 ARG A 598 ARG A 602 5 5 HELIX 15 15 ALA A 604 SER A 618 1 15 SHEET 1 A 5 LEU A 363 SER A 371 0 SHEET 2 A 5 LEU A 376 TRP A 382 -1 O LEU A 379 N GLN A 367 SHEET 3 A 5 ASP A 386 THR A 392 -1 O ILE A 390 N HIS A 378 SHEET 4 A 5 CYS A 432 GLU A 436 -1 O PHE A 435 N ALA A 389 SHEET 5 A 5 LEU A 421 CYS A 425 -1 N GLY A 423 O VAL A 434 SHEET 1 B 2 CYS A 488 VAL A 490 0 SHEET 2 B 2 ILE A 496 VAL A 498 -1 O LYS A 497 N LEU A 489 CISPEP 1 ALA A 429 PRO A 430 0 -0.89 SITE 1 AC1 16 PHE A 403 ALA A 407 MET A 410 LEU A 413 SITE 2 AC1 16 VAL A 419 GLN A 420 LEU A 421 GLY A 423 SITE 3 AC1 16 VAL A 424 PHE A 435 SER A 499 ASP A 500 SITE 4 AC1 16 PHE A 501 PHE A 506 HOH A 869 HOH A 887 CRYST1 40.520 68.900 49.460 90.00 106.88 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024679 0.000000 0.007489 0.00000 SCALE2 0.000000 0.014514 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021129 0.00000